Cargando…

Putative novel mediators of acute kidney injury in critically ill patients: handling by continuous venovenous hemofiltration and effect of anticoagulation modalities

BACKGROUND: Novel putative mediators of acute kidney injury (AKI) include immune-cell derived tumour necrosis factor-like weak inducer of apoptosis (TWEAK), angiopoietin-2 (Ang-2) and protein pentraxin-3 (PTX3). The effect of continuous venovenous hemofiltration (CVVH) and different anticoagulation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schilder, Louise, Nurmohamed, S. Azam, ter Wee, Pieter M., Paauw, Nanne J., Girbes, Armand RJ, Beishuizen, Albertus, Beelen, Robert HJ, Groeneveld, AB Johan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4628303/ https://www.ncbi.nlm.nih.gov/pubmed/26519056 http://dx.doi.org/10.1186/s12882-015-0167-5

Ejemplares similares

The plasma level and biomarker value of neutrophil gelatinase-associated lipocalin in critically ill patients with acute kidney injury are not affected by continuous venovenous hemofiltration and anticoagulation applied
por: Schilder, Louise, et al.
Publicado: (2014)

Citrate confers less filter-induced complement activation and neutrophil degranulation than heparin when used for anticoagulation during continuous venovenous haemofiltration in critically ill patients
por: Schilder, Louise, et al.
Publicado: (2014)

Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: a multi-center randomized clinical trial
por: Schilder, Louise, et al.
Publicado: (2014)

Fluid balance-adjusted creatinine at initiation of continuous venovenous hemofiltration and mortality. A post-hoc analysis of a multicenter randomized controlled trial.
por: Stads, Susanne, et al.
Publicado: (2018)

Determinants of Outcome in Non-Septic Critically Ill Patients with Acute Kidney Injury on Continuous Venovenous Hemofiltration
por: Koning, Mark V., et al.
Publicado: (2011)

Interfacing the ICU with the general practitioner
por: Girbes, Armand RJ, et al.
Publicado: (2010)

Predicting outcome of rethoracotomy for suspected pericardial tamponade following cardio-thoracic surgery in the intensive care unit
por: ten Tusscher, Birkitt L, et al.
Publicado: (2011)

The effects of continuous venovenous hemofiltration on coagulation activation
por: Bouman, Catherine SC, et al.
Publicado: (2006)

Intermittent versus continuous enoxaparine for anticoagulation during continuous venovenous hemofiltration
por: Koroljov, A, et al.
Publicado: (2008)

The removal of cystatin C during continuous venovenous hemofiltration
por: Bouman, Catherine S. C., et al.
Publicado: (2011)

Continuous venovenous haemofiltration with citrate-buffered replacement solution is safe and efficacious in patients with a bleeding tendency: a prospective observational study
por: Nurmohamed, Shaikh A, et al.
Publicado: (2013)

Comparing adsorption of gentamicin by polyacrylonitrile and polyamide hemofiltration filter in an in vitro continuous venovenous hemofiltration model
por: Lam, P, et al.
Publicado: (2009)

Predicting a low cortisol response to adrenocorticotrophic hormone in the critically ill: a retrospective cohort study
por: de Jong, Margriet FC, et al.
Publicado: (2007)

Influence of continuous venovenous hemofiltration on transpulmonary thermodilution-derived parameters
por: Neirynck, V, et al.
Publicado: (2009)

Methotrexate toxicity treated with continuous venovenous hemofiltration, leucovorin and glucarpidase
por: Connors, Nicholas J., et al.
Publicado: (2014)

Bioenergetic Balance of Continuous Venovenous Hemofiltration, a Retrospective Analysis
por: Jonckheer, Joop, et al.
Publicado: (2022)

Pharmacokinetics of linezolid in critically ill patients undergoing continuous venovenous hemofiltration
por: Meyer, B, et al.
Publicado: (2004)

Immunomodulatory Effect of Continuous Venovenous Hemofiltration during Sepsis: Preliminary Data
por: Servillo, Giuseppe, et al.
Publicado: (2013)

Hemostasis during low molecular weight heparin anticoagulation for continuous venovenous hemofiltration: a randomized cross-over trial comparing two hemofiltration rates
por: Oudemans-van Straaten, Heleen M, et al.
Publicado: (2009)

Continuous venovenous hemofiltration versus extended daily hemofiltration in patients with septic acute kidney injury: a retrospective cohort study
por: Sun, Zhiping, et al.
Publicado: (2014)

Steroidogenesis in the adrenal dysfunction of critical illness: impact of etomidate
por: Molenaar, Nienke, et al.
Publicado: (2012)

Pharmacokinetics and pharmacodynamics of danaparoid during continuous venovenous hemofiltration: a pilot study
por: de Pont, Anne-Cornélie JM, et al.
Publicado: (2007)

High-dose continuous venovenous hemofiltration combined with charcoal hemoperfusion for methotrexate removal
por: Grafft, Carrie, et al.
Publicado: (2011)

Effects of continuous venovenous hemofiltration on vancomycin trough concentrations in critically ill children
por: Peng, Lengyue, et al.
Publicado: (2021)

A Retrospective Review of the Use of Regional Citrate Anticoagulation in Continuous Venovenous Hemofiltration for Critically Ill Patients
por: Leung, Anne Kit-Hung, et al.
Publicado: (2013)

Hypothalamo-pituitary-adrenal axis activity after intracranial catastrophies: what is enough?
por: Groeneveld, AB Johan, et al.
Publicado: (2009)

Metabolism of Albumin after Continuous Venovenous Hemofiltration in Patients with Systemic Inflammatory Response Syndrome
por: Chen, Yu, et al.
Publicado: (2015)

Severe Metformin Poisoning Successfully Treated with Simultaneous Venovenous Hemofiltration and Prolonged Intermittent Hemodialysis
por: Leonaviciute, Dovile, et al.
Publicado: (2018)

Metabolic Acidosis and Hyperlactatemia Requiring Continuous Venovenous Hemofiltration after Intentional Ingestion of Metformin
por: Cruz, Maricel Dela, et al.
Publicado: (2021)

Early high protein intake is associated with low mortality and energy overfeeding with high mortality in non-septic mechanically ventilated critically ill patients
por: Weijs, Peter JM, et al.
Publicado: (2014)

Insulin: a wonder drug in the critically ill?
por: Johan Groeneveld, AB, et al.
Publicado: (2002)

Continuous venovenous hemofiltration in severely burned patients with acute kidney injury: a cohort study
por: Chung, Kevin K, et al.
Publicado: (2009)

Experience with continuous venovenous hemofiltration (CVVH) in the ICU: a report from a single center
por: Nalbandi, V, et al.
Publicado: (2001)

Evaluation of the potential adverse effects associated with calcium carbonate precipitate during continuous venovenous hemofiltration
por: McKee, J, et al.
Publicado: (2012)

The Effect of Bicarbonate Administration via Continuous Venovenous Hemofiltration on Acid-Base Parameters in Ventilated Patients
por: Allegretti, Andrew S., et al.
Publicado: (2015)

Continuous venovenous hemofiltration using customized replacement fluid for acute kidney injury with severe hypernatremia
por: Paquette, François, et al.
Publicado: (2016)

Continuous venovenous hemofiltration in the management of paraquat poisoning: A meta-analysis of randomized controlled trials
por: Lin, Guodong, et al.
Publicado: (2017)

Anti-Xa level monitoring of low-molecular-weight heparin during intermittent venovenous hemofiltration
por: Xu, Lengnan, et al.
Publicado: (2023)

Experiences with Continuous Venovenous Hemofiltration using 18mmol/L predilution Citrate anticoagulation and a Phosphate Containing Replacement Solution
por: Jeffrey, Yuen Henry, et al.
Publicado: (2017)

High-volume continuous venovenous hemofiltration reduces mortality in critically ill patients with acute renal failure
por: Van Ketel, R, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_o99u7u5164tnt3rqk9d2ak45cr